GlassScriptPhysician profile
Carmen Rosario
NPI 1629230446
$2,666.84
in general payments reported to CMS, 2019-2025
12 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,035 · 2020: $224 · 2021: $40.54 · 2023: $327 · 2024: $406 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,367.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,254.36 | 2021-2025 | Qulipta, Ubrelvy |
| Glaxosmithkline, LLC. | $673.11 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $268.21 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $158.89 | 2019-2020 | |
| Tg Therapeutics, INC. | $125.00 | 2025 | |
| Chiesi USA, INC. | $56.65 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $29.80 | 2019 | |
| Electromed, INC. | $27.25 | 2019 | |
| La Jolla Pharmaceutical Company | $21.60 | 2019 | |
| Mylan Specialty L.P. | $20.62 | 2019 | |
| Advanced Respiratory, INC | $15.90 | 2020 | |
| Astellas Pharma US INC | $15.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Rosario listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.